Pharmacy services provider Omnicare Inc has extended its offer to acquire shares of smaller rival PharMerica Corp to Jan. 20, 2012.PharMerica, which has twice rejected Omnicare's $441 million offer since late August, has also adopted a poison pill to thwart the acquisition.In October, Omnicare had extended its tender offer to shareholders of PharMerica by two months to Dec. 2.While Omnicare shares closed at $33.14, PharMerica shares closed at $15.30 on Friday on the New York Stock Exchange.
Omnicare, Inc. (Omnicare) is a pharmaceutical services company. Shares of OCR remained unchanged at $33.14. In the past year, the shares have traded as low as $20.36 and as high as $33.20. On average, 2084590 shares of OCR exchange hands on a given day and today's volume is recorded at 0.
Source
